ENTITY
Cellivery Therapeutics

Cellivery Therapeutics (268600 KS)

3
Analysis
Health CareSouth Korea
Cellivery Therapeutics, Inc. operates as a pharmaceutical company. The Company develops and sells proteins drugs and other products, as well as conducts research and development activities. Cellivery Therapeutics markets its products throughout Korea.
more
Refresh
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x